查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922443

日本药物筛检市场报告：按产品/服务、检体类型、最终用户和地区划分，2026-2034年

Japan Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本药物筛检市场规模达4.644亿美元。 IMARC集团预测，到2034年，该市场规模将达到14.614亿美元，2026年至2034年的复合年增长率（CAGR）为13.59%。推动该市场成长的关键因素包括：毒品贩运者和本地毒贩活动的增加、毒品滥用案件的激增以及虚拟货币的日益普及。

药物筛检是指采集并检测个人血液、尿液、毛髮或唾液样本，以识别是否有指示药物使用的物质或化学物质。该过程涉及多种检测方法，包括酵素免疫分析法(EIA)、气相层析法(GC) 和液相层析法/质谱联用 (LC/MS)。特别是 LC/MS，被认为是一种优秀的、高度准确的确认性检测方法，可用于初次检测呈阳性后进行确认。其主要目的是检测合法和非法药物的使用情况，包括可卡因、海洛因和 3,4-亚甲基安非他命(MDMA) 等非法物质。它也用于识别处方药的滥用情况，这些滥用通常以不同的方式服用或过量服用。药物筛检在评估新药疗效和安全性的临床试验中发挥重要作用。它也是刑事执法程序的重要组成部分。此外，它还有助于评估接受鸦片类药物治疗的患者的潜在滥用风险和药物顺从性。

日本药物筛检市场趋势：

受多种因素影响，日本药物筛检市场目前正经历显着成长。其中，关键驱动因素是各应用领域对准确快速检测结果的需求不断增长。此外，随着社会面临成瘾的挑战，药物滥用案件的增加也成为市场扩张的主要动力。另一个促进市场成长的因素是，人们普遍使用药物来应对压力、焦虑和生活困境，这进一步凸显了有效药物筛检的必要性。此外，政府机构也发挥关键作用，实施常规路边口腔液筛检以检测受药物影响的驾驶员，并启动药物滥用和成瘾预防计画以满足成瘾的需求。此外，加密货币的使用为买卖双方提供了匿名性，也助长了毒贩和本地经销商的活动，从而推动了市场推出。这些因素共同作用，将使日本药物筛检市场在预测期内保持积极前景。

本报告解答的关键问题

  • 日本药物筛检市场目前表现如何？未来几年又将如何发展？
  • 新冠疫情对日本药物筛检市场感染疾病了哪些影响？
  • 日本药物筛检市场按产品和服务分類的组成是什么？
  • 日本药物筛检市场依样本类型分類的组成是怎样的？
  • 日本药物筛检市场依最终用户分類的组成是怎样的？
  • 日本药物筛检市场价值链的不同阶段有哪些？
  • 日本药物筛检的主要驱动因素和挑战是什么？
  • 日本药物筛检市场的结构是怎么样的？主要参与者有哪些？
  • 日本的药物筛检市场竞争有多激烈？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章 日本药物筛检市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本药物筛检市场概述

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本药物筛检市场－依产品及服务细分

  • 装置
  • 快速检测装置
  • 消耗品
  • 检查室服务

7. 日本药物筛检市场－依样本类型细分

  • 尿液检体
  • 呼吸样本
  • 口腔液样本
  • 头髮样本
  • 其他的

第八章：日本药物筛检市场－依最终用户细分

  • 医院
  • 药物检测实验室
  • 职场
  • 药物治疗中心
  • 疼痛管理中心
  • 个人用户
  • 刑事司法系统与执法机关

第九章：日本药物筛检市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本药物筛检市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章：日本药物筛检市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A19553

Japan drug screening market size reached USD 464.4 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 1,461.4 Million by 2034 , exhibiting a growth rate (CAGR) of 13.59% during 2026-2034 . The market is being propelled by several significant factors, including the escalating presence of drug traffickers and local dealers, a surge in substance abuse cases, and the growing utilization of virtual currencies.

Access the full market insights report Request Sample

Drug screening involves the procedure of collecting and examining an individual's blood, urine, hair, or saliva to identify the presence of substances and chemicals indicative of drug use. This process encompasses a wide array of testing methods, including enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is considered a superior and highly precise confirmation test utilized when initial results show positive. Its primary purpose is to detect both the legitimate and illegitimate use of drugs, spanning illegal substances like cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). Additionally, it is employed to identify the misuse of various prescription medications when they are consumed differently or in excessive quantities. Drug screening plays a crucial role in clinical trials for evaluating the effectiveness and safety of novel drugs. Moreover, it is an essential component in legal proceedings, serving the purposes of criminal law enforcement. Furthermore, it aids in assessing the potential for abuse and adherence among patients receiving opioid therapy.

JAPAN DRUG SCREENING MARKET TRENDS:

The Japan drug screening market is currently experiencing significant growth driven by a multitude of influential factors. Foremost among these factors is the rising demand for drug screening due to its accuracy and the rapid delivery of results, making it an appealing choice for various applications. Moreover, the increase in cases of substance abuse is a key driver of market expansion, as societies grapple with the challenges of addiction and its consequences. Another factor contributing to the market's growth is the growing prevalence of drug use as a coping mechanism for stress, anxiety, and life's hardships, further emphasizing the need for effective drug screening. Additionally, government agencies are also playing a pivotal role by initiating regular roadside oral fluid screening to detect drug-impaired drivers and launching substance abuse and addiction programs to address the needs of addicts. Furthermore, the presence of drug traffickers and local dealers, facilitated by the use of virtual currencies that offer anonymity to buyers and sellers, is supporting the market's expansion. These factors will collectively contribute to the positive outlook for the drug screening market in Japan over the forecasted period.

JAPAN DRUG SCREENING MARKET SEGMENTATION:

Product and Service Insights:

  • To get detailed segment analysis of this market Request Sample
  • Equipment Immunoassay Analyzers Chromatography Instruments Breath Analyzers
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
  • Rapid Testing Devices Urine Testing Devices Oral Fluid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
  • Consumables Assay Kits Sample Collection Cups Calibrators and Controls Others
  • Assay Kits
  • Sample Collection Cups
  • Calibrators and Controls
  • Others
  • Laboratory Services
  • Equipment Immunoassay Analyzers Chromatography Instruments Breath Analyzers
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
  • Rapid Testing Devices Urine Testing Devices Oral Fluid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
  • Consumables Assay Kits Sample Collection Cups Calibrators and Controls Others
  • Assay Kits
  • Sample Collection Cups
  • Calibrators and Controls
  • Others
  • Assay Kits
  • Sample Collection Cups
  • Calibrators and Controls
  • Others
  • Assay Kits
  • Sample Collection Cups
  • Calibrators and Controls
  • Others
  • Laboratory Services

Sample Type Insights:

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Others
  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Others

End User Insights:

  • Hospitals
  • Drug Testing Laboratories
  • Workplaces
  • Drug Treatment Centers
  • Pain Management Centers
  • Personal Users
  • Criminal Justice System and Law Enforcement Agencies
  • Hospitals
  • Drug Testing Laboratories
  • Workplaces
  • Drug Treatment Centers
  • Pain Management Centers
  • Personal Users
  • Criminal Justice System and Law Enforcement Agencies

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan drug screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan drug screening market?
  • What is the breakup of the Japan drug screening market on the basis of product and service?
  • What is the breakup of the Japan drug screening market on the basis of sample type?
  • What is the breakup of the Japan drug screening market on the basis of end user?
  • What are the various stages in the value chain of the Japan drug screening market?
  • What are the key driving factors and challenges in the Japan drug screening?
  • What is the structure of the Japan drug screening market and who are the key players?
  • What is the degree of competition in the Japan drug screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Screening Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Drug Screening Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Drug Screening Market - Breakup by Product and Service

  • 6.1 Equipment
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Immunoassay Analyzers
      • 6.1.3.2 Chromatography Instruments
      • 6.1.3.3 Breath Analyzers
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Rapid Testing Devices
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Urine Testing Devices
      • 6.2.3.2 Oral Fluid Testing Devices
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 Consumables
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Assay Kits
      • 6.3.3.2 Sample Collection Cups
      • 6.3.3.3 Calibrators and Controls
      • 6.3.3.4 Others
    • 6.3.4 Market Forecast (2026-2034)
  • 6.4 Laboratory Services
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)

7 Japan Drug Screening Market - Breakup by Sample Type

  • 7.1 Urine Samples
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Breath Samples
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Oral Fluid Samples
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Hair Samples
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2020-2025)
    • 7.5.2 Market Forecast (2026-2034)

8 Japan Drug Screening Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Drug Testing Laboratories
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Workplaces
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Drug Treatment Centers
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Pain Management Centers
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)
  • 8.6 Personal Users
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Forecast (2026-2034)
  • 8.7 Criminal Justice System and Law Enforcement Agencies
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Forecast (2026-2034)

9 Japan Drug Screening Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product and Service
    • 9.1.4 Market Breakup by Sample Type
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product and Service
    • 9.2.4 Market Breakup by Sample Type
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product and Service
    • 9.3.4 Market Breakup by Sample Type
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product and Service
    • 9.4.4 Market Breakup by Sample Type
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product and Service
    • 9.5.4 Market Breakup by Sample Type
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product and Service
    • 9.6.4 Market Breakup by Sample Type
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product and Service
    • 9.7.4 Market Breakup by Sample Type
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product and Service
    • 9.8.4 Market Breakup by Sample Type
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Drug Screening Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Drug Screening Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix